Table 1. Clinical characteristics of CML patients recruited at diagnosis.
Patients | Gender | 1Age | BCR/ABL transcript levels | WBC (103/µL) | HGB (g/dL) | PLT (103/µL) | LDH (mg/dL) | Liver (cm)2 | Spleen (cm)2 | Sokal risk group | Gr-MDSCs (%) | Mo-MDSC (%) |
1 | M | 59 | 25,14 | 75,6 | 15,3 | 20 | - | 0 | 0 | low | 87 | 18,9 |
2 | F | 48 | 81,88 | 67,14 | 8,1 | 458 | 1043 | 2 | 14 | high | 86 | 41 |
3 | F | 71 | 48,16 | 70,5 | 9,2 | 338 | 2230 | - | - | intermediate | 89 | 46,8 |
4 | M | 70 | 349,51 | 71,2 | 13,5 | 370 | 715 | 0 | 0 | intermediate | 79 | 81,2 |
5 | F | 66 | 126,73 | 27,6 | 12,9 | 294 | 888 | 2 | 3 | intermediate | 82 | 12,4 |
6 | M | 38 | 65,61 | 28,8 | 13,6 | 232 | - | 0 | 0 | low | 83,4 | 28,5 |
7 | M | 21 | 126,51 | 144 | 14,2 | 107 | 1247 | 0 | 6 | low | 83,7 | 81,6 |
8 | M | 53 | 142,78 | 24,8 | 16,6 | 311 | 288 | 0 | 3 | low | 83 | 63 |
9 | M | 48 | 40,33 | 259,9 | 9,9 | 350 | 1074 | 7 | 14 | intermediate | 90 | 41 |
10 | F | 64 | 28,21 | 55 | 10,6 | 531 | 1147 | 0 | 2 | intermediate | 58,3 | 1 |
11 | F | 57 | 122,97 | 15,3 | 11,4 | 273 | 1124 | 2 | 1 | low | 88 | 61 |
12 | M | 36 | 56,24 | 136,6 | 10,8 | 208 | 1352 | 7 | 8 | low | 87 | 42,4 |
13 | M | 52 | 14,89 | 46 | 10,2 | 418 | 1820 | 0 | 2 | low | 78 | 25 |
14 | F | 58 | 150,04 | 122 | 10,7 | 361 | 1693 | 0 | 3 | int | 75 | 50 |
15 | F | 65 | 191,66 | 87 | 15,3 | 252 | 688 | 0 | 0 | low | 50 | 91,2 |
16 | M | 72 | 71,98 | 211,9 | 13 | 168 | 345 | 2 | 4 | int | 75 | 14,4 |
17 | F | 78 | 48,22 | 58,5 | 11,7 | 651 | - | 0 | 1 | high | 64 | 5,4 |
18 | M | 37 | 153,59 | 104,3 | 12,8 | 344 | 1635 | 0 | 0 | low | 82,5 | 2,8 |
19 | M | 69 | 62 | 85 | 12,2 | 320 | 260 | 0 | 0 | low | 83 | 25 |
Abbreviations: F, Female; M, male; WBC, white blood cells; HGB, hemoglobin; PLT, platelets; LDH, lactate dehydrogenase. PB: peripheral blood. Liver and spleen, cm below the costal margin. 1Age at diagnosis.